Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

RECOVER-ENERGIZE Platform Protocol

ClinicalTrials.gov ID: NCT06404047

Public ClinicalTrials.gov record NCT06404047. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 7:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

RECOVER-ENERGIZE: A Platform Protocol for Evaluation of Interventions for Exercise Intolerance in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with incorporation into clinical COVID-19 management programs and treatment plans if results achieve key study outcomes. This protocol is a prospective, multi-center, multi-arm, randomized, controlled platform trial evaluating interventions to address and improve exercise intolerance and post-exertional malaise (PEM) as manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). The focus of this protocol is to assess interventions that can improve exercise capacity, daily activities tolerance, and quality of life in patients with PASC.

Study identification

NCT ID
NCT06404047
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Duke University
Other
Enrollment
660 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 17, 2024 (Actual)
Primary completion
Oct 30, 2025 (Actual)
Completion
Oct 30, 2025 (Actual)
Last update posted
Nov 14, 2025

2024 – 2025

United States locations

U.S. sites
42
U.S. states
27
U.S. cities
36
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35205 —
Banner University Medical Center Phoenix Phoenix Arizona 85006 —
Banner University Medical Center Tucson Tucson Arizona 85719 —
Stanford University Stanford California 94035 —
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Torrance California 90509 —
University of Colorado Aurora Colorado 80045 —
Yale - New Haven Hospital New Haven Connecticut 06520-8017 —
University of Florida College of Medicine Jacksonville Jacksonville Florida 32209 —
Innovation Clinical Trials Inc. Miami Florida 33144 —
Valencia Medical and Research Center Miami Florida 33165 —
Grady Memorial Hospital (Emory) Atlanta Georgia 30303 —
Emory Hope Clinic Decatur Georgia 30030 —
University of Illinois at Chicago Chicago Illinois 60608 —
Rush University Medical Center Chicago Illinois 60612 —
North Shore University HealthSystem/Evanston Hospital Evanston Illinois 60201 —
Saint Francis Medical Center Peoria Illinois 61637 —
Cedar Valley Clinical Research Waterloo Iowa 50701 —
Kansas University Medical Center Kansas City Kansas 66160 —
University of Kentucky Lexington Kentucky 40536 —
Maine Health Institute of Research Scarborough Maine 04074 —
Tufts Medical Center Boston Massachusetts 02111 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Beth Israel Deaconess Med. Ctr. Boston Massachusetts 02215 —
Henry Ford Hospital Detroit Michigan 48202 —
Mayo Clinic Rochester Minnesota 55905 —
Washington University School of Medicine St Louis Missouri 63110 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 —
University of New Mexico Health Sciences Center Albuquerque New Mexico 87102 —
NYU Langone Health/Brooklyn Hospital Brooklyn New York 11220 —
University of North Carolina Hospital Chapel Hill North Carolina 27514 —
Duke University Medical Center Durham North Carolina 27710 —
Oregon Health and Science University Portland Oregon 97239-3098 —
University of Pittsburgh Pittsburgh Pennsylvania 15213 —
Avera McKennan Hospital & University Health Center Sioux Falls South Dakota 57108 —
Southwest Family Medicine Associates Dallas Texas 75235 —
Houston Methodist Hospital Houston Texas 77030 —
University of Texas Health Science Center at Houston Houston Texas 77030 —
University of Utah Salt Lake City Utah 84132 —
Vermont Lung Center, University of Vermont Colchester Vermont 05446 —
University Physicians and Surgeons, Inc dba Marshall Health Huntington West Virginia 25701 —
West Virginia Clinical and Translational Science Institute Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06404047, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 14, 2025 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06404047 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →